Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-23

FDA Approved: NOVAREL — Supplemental Application (Ferring Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for NOVAREL (chorionic gonadotropin) from Ferring Pharmaceuticals, indicating a regulatory update to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOVAREL (GONADOTROPHIN, CHORIONIC)

Snippet

SUPPL AP for NOVAREL (GONADOTROPHIN, CHORIONIC)